2020
DOI: 10.5811/cpcem.2020.5.46955
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Introduction: Immune thrombocytopenic purpura (ITP) is an autoimmune-mediated disorder in which the body produces antibodies that destroy platelets, causing an increased risk of bleeding and bruising. Tranexamic acid (TXA) is a medication that prevents clot breakdown and is used to treat uncontrolled bleeding. Case Report: We present the case of an 11-year-old female with significant epistaxis and hypotension in the emergency department. Traditional therapies were initiated; however, the patient continued t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 20 publications
(31 reference statements)
0
1
0
Order By: Relevance
“…Antifibrinolytics (tranexamic acid and aminocaproic acid) are successfully used to control significant bleeding in patients with ITP [ 102 , 103 , 104 ]. Oral contraceptives can be used in female patients with menorrhagia.…”
Section: Treatment Of Itpmentioning
confidence: 99%
“…Antifibrinolytics (tranexamic acid and aminocaproic acid) are successfully used to control significant bleeding in patients with ITP [ 102 , 103 , 104 ]. Oral contraceptives can be used in female patients with menorrhagia.…”
Section: Treatment Of Itpmentioning
confidence: 99%